# Mirvie

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mirvie

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.mirvie.com
- Total disclosed funding: $114M
- Latest round: Series C (Jul 18, 2025)
- Investors on record: 9

## About

Based in California, US, and founded in 2019, by Maneesh Jain, and Stephen Quake, Mirvie, Inc. also known as Mirvie, is an organization that helps in the early detection of any complication during pregnancy even before it happens. In July 2025, Mirvie, Inc. raised USD 23.7 million in series B funding led by new investor BlackRock, with participation from returning investors Decheng Capital, Foresite Capital, General Catalyst Partners, GV, Khosla Ventures, and Mayfield Fund. Other unspecified investors also participated in the round. Mirvie is a company that provides a personalized window in pregnancy by predicting unexpected pregnancy complications before they become a crisis. The company uses a simple blood test to detect any complications long before they occur through its RNA platform. This RNA platform of the company finds out the most important information about pregnancy’s unique biology by analyzing RNA messages derived from the baby, the placenta, and the mom, with the help of machine learning. The company will use the July 2025 funding to expand its flagship product.

## Funding rounds

- Series C, Jul 18, 2025, $24M — Mayfield Fund, General Catalyst Partners, Khosla Ventures, GV, BlackRock, Foresite Capital, Decheng Capital
- Series B, May 17, 2022, $60M — Mayfield Fund, General Catalyst Partners, Khosla Ventures, GV, Comerica Bank, Foresite Capital, Decheng Capital
- Series B, Apr 7, 2020, $25M — Synetro Group
- Series A, Jan 1, 2018, $5.8M — Khosla Ventures

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B, Series C
- Synetro Group (https://capitalatlas.ai/funds/synetro-group) — Series B
- Mayfield Fund (https://capitalatlas.ai/funds/mayfield-fund) — Series B, Series C
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series B, Series C
- GV (https://capitalatlas.ai/funds/gv) — Series B, Series C
- Comerica Bank — Series B
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series B, Series C
- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series B, Series C
- BlackRock (https://capitalatlas.ai/funds/blackrock) — Series C